ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018


View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

State of the art session: Airways disease

Chairs: I. Horváth (Budakeszi, Hungary), A. Spanevello (Milan, Italy)
Aims: This session will highlight the latest developments and controversies in airways disease. Four key areas will be covered that have provided critical new observations in the past year that will help to diagnose and treat subsets of patients with asthma and chronic obstructive pulmonary disease (COPD). The new observations range from novel ways of defining the mechanisms that underpin the disease in an individual patient by using the appropriate selective biomarkers (molecular phenotyping) to how this information can shape new targeted approaches to the treatment of asthma and COPD (biological agents in airways disease). The session will also cover the role of macrolides for treating severe asthma exacerbations and what this can reveal about disease mechanisms and how we can use blood biomarkers to identify the COPD patients who could benefit from current and novel therapies. At the end of this session, delegates will have the most up-to-date, clear and practical take-home knowledge relating to the diagnosis, treatment and prevention of severe asthma and COPD.
Molecular phenotyping of asthma comes of age
S. Wenzel (Pittsburgh, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Macrolides, inflammation and the lung microbiome: cause or effect?
P. Gibson (Newcastle, Australia)
WebcastSlide presentation
WebcastSlide presentation
Are we really transforming asthma and COPD management with biologics?
N. Hanania (Houston, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Eosinophils in COPD: do they predict drug response?
D. Singh (Manchester, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation